Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab. [electronic resource]
Publication details: Hematology, transfusion and cell therapy Description: 364-367 p. digitalISSN:- 2531-1387
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.